Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months
In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles
Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions
DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal
DRCCA Board Gets Tough on Concept Proposals, Okays Several Anyway
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









